← Product Code [DCK](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DCK) · K963061

# IMMAGE IMMUNOCHEMISTRY SYSTEM C-REACTIVE PROTEIN (CRP) REAGENT (K963061)

_Beckman Instruments, Inc. · DCK · Nov 4, 1996 · Immunology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DCK/K963061

## Device Facts

- **Applicant:** Beckman Instruments, Inc.
- **Product Code:** [DCK](/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DCK.md)
- **Decision Date:** Nov 4, 1996
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 866.5270
- **Device Class:** Class 2
- **Review Panel:** Immunology

## Indications for Use

The IMMAGE Immunochemistry Systems C-reactive protein (CRP) reagent, in conjunction with Beckman CAL 5 Plus, is intended for use in the quantitative determination of human C-reactive protein concentrations in human serum and plasma samples by rate nephelometry. This assay is designed for use with Beckman's IMMAGE Immunochemistry System.

## Device Story

The IMMAGE Immunochemistry System CRP reagent is an in vitro diagnostic assay used for the quantitative measurement of C-reactive protein in human serum and plasma. The device utilizes rate nephelometry and latex particle-enhanced immunochemistry to detect CRP concentrations. It is designed for operation on the Beckman IMMAGE Immunochemistry System in a clinical laboratory setting by trained laboratory personnel. The system processes samples to produce a quantitative concentration value, which is reported to the healthcare provider. This output assists clinicians in evaluating inflammatory states in patients. The reagent is provided in a liquid stable form, offering improved stability compared to lyophilized alternatives.

## Clinical Evidence

Bench testing only. Method comparison study against Behring N Latex CRP (n=not specified) yielded a slope of 1.037, intercept of -0.06, and correlation coefficient (r) of 0.991. Imprecision studies demonstrated within-run %CVs ranging from 1.8% to 8.1% across three concentration levels (1.65–12.6 mg/dL). Stability data confirms a 24-month shelf-life and 14-day open-container/calibration stability.

## Technological Characteristics

Latex particle-enhanced immunochemistry; rate nephelometry detection principle. Reagent is liquid stable. Uses goat-derived antibodies. Designed for use on the IMMAGE Immunochemistry System. No specific ASTM material standards or connectivity protocols provided.

## Regulatory Identification

A C-reactive protein immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the C-reactive protein in serum and other body fluids. Measurement of C-reactive protein aids in evaluation of the amount of injury to body tissues.

## Predicate Devices

- Behring N Latex CRP

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

200 South Kraemer Boulevard, Box 8000, Brea, CA 92822-8000 • (714) 993-5321

NOV - 4 1996

BECKMAN

Summary of Safety &amp; Effectiveness

IMMAGE™ Immunochemistry System C-Reactive Protein (CRP) Reagent

K963061

Revised

Dmc: Dated 10/4/96

1.0 Submitted By:

Annette Hellie
Regulatory Specialist, Product Submissions
Beckman Instruments, Inc.
200 S. Kraemer Blvd., W-337
Brea, California 92822-8000
Telephone: (714) 993-8767
FAX: (714) 961-4457

2.0 Date Submitted:

06 Aug-1996

3.0 Device Name(s):

3.1 Proprietary Names

IMMAGE™ Immunochemistry System C-Reactive Protein (CRP) Reagent

3.2 Classification Names

C-reactive protein immunological test system(21 CFR 866.5270)

4.0 Predicate Device(s):

Behring N Latex CRP

5.0 Description:

The IMMAGE Immunochemistry Systems C-reactive protein (CRP) reagent, in conjunction with Beckman CAL 5 Plus, is intended for use in the quantitative determination of human C-reactive protein concentrations in human serum and plasma samples.

6.0 Intended Use:

The IMMAGE Immunochemistry Systems C-reactive protein (CRP) reagent, in conjunction with Beckman CAL 5 Plus, is intended for use in the quantitative determination of human C-reactive protein concentrations in human serum and plasma samples by rate nephelometry. This assay is designed for use with Beckman's IMMAGE Immunochemistry System.

file: irf510k.see

Beckman Instruments, Inc.

twx: 910-592-1260 • telex: 06-78413

{1}

Beckman Instruments, Inc., Section 510(k) Notification
IMMAGE™ Immunochemistry System C-Reactive Protein (CRP) Reagent
Summary of Safety &amp; Effectiveness

# 7.0 Comparison to Predicate(s):

The following table shows similarities and differences between the predicates identified in Section 4.0 of this summary.

|  Reagent | Aspect/Characteristic | Comments  |
| --- | --- | --- |
|  SIMILARITIES  |   |   |
|  IMMAGE System (CRP) Reagent | Intended Use | Same as Behring N Latex CRP  |
|   |  Nephelometric methodology | Same as Behring N Latex CRP  |
|   |  Use of Latex particle technology | Same as Behring N Latex CRP  |
|  DIFFERENCES  |   |   |
|  IMMAGE System (CRP) Reagent | Form of reagent | the IMMAGE CRP is liquid stable while Behring N Latex CRP reagent is lyophilized  |
|   |  Antibody source | IMMAGE CRP uses goat while Behring N Latex CRP uses rabbit.  |
|   |  Stability | IMMAGE CRP is stable for 14 days once opened, properly stored while Behring N Latex CRP reagent is stable for one week following reconstitution,.  |

file: crp510k.sse

{2}

Beckman Instruments, Inc., Section 510(k) Notification
IMMAGE™ Immunochemistry System C-Reactive Protein (CRP) Reagent
Summary of Safety &amp; Effectiveness
3

## 8.0 Summary of Performance Data:

The data in the Premarket Notification on safety and effectiveness supports a finding of substantial equivalence to chemistry test systems already in commercial distribution. Equivalence is demonstrated through method comparison, stability, and imprecision experiments that relate results obtained from the Behring N Latex CRP Reagent to the IMMAGE CRP Reagent.

### Method Comparison Study Results
IMMAGE CRP Reagent vs. Behring N Latex CRP Reagent

|  Analyte | Slope | Intercept | r | Predicate  |
| --- | --- | --- | --- | --- |
|  IMMAGE CRP | 1.037 | -0.06 | 0.991 | Behring N Latex CRP  |

### Stability Study Results

|  Reagent | Product Claim  |
| --- | --- |
|  IMMAGE CRP | 24 month shelf-life
14 day open container stability
14 day calibration stability  |

### Estimated Within-Run Imprecision

|  MATERIAL | MEAN (mg/dL) | SD (mg/dL) | %CV | Number of Results  |
| --- | --- | --- | --- | --- |
|  CRP Reagent  |   |   |   |   |
|  Level 1 | 1.65 | 0.134 | 8.1 | 80  |
|  Level 2 | 5.41 | 0.165 | 3.1 | 80  |
|  Level 3 | 12.6 | 0.22 | 1.8 | 80  |

This summary of safety and effectiveness is being submitted in accordance with the requirements of the Safe Medical Device Act of 1990 and the implementing regulation 21 CFR 807.92.

file: crp510k.sse

---

**Source:** [https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DCK/K963061](https://fda.innolitics.com/submissions/IM/subpart-f%E2%80%94immunological-test-systems/DCK/K963061)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
